[Drug therapy of angina pectoris. Are the possibilities exploited well enough?].
A retrospective comparative study of the use of antianginal drugs in 1987 and 1992/93 has been carried out in unselected series of patients admitted for angiographic evaluation. Compared with the patients in 1987 the patients in 1992/93 were treated with approximately 50% of the doses of beta-blockers and isosorbide dinitrate. There was also a considerable reduction of the proportion of patients who received doses of beta-blockers of a similar level as used in large multicentre studies showing improved survival after myocardial infarction. The explanation of this change in therapy may be due, at least partly, to a general fear of side-effects.
Forfang
K
K
Medisinsk avdeling B, Rikshospitalet, Oslo.
Gullestad
L
L
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D000789:Angina, Unstable / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D013999:Timolol; D011433:Propranolol; D008790:Metoprolol; D007548:Isosorbide Dinitrate
Medikamentell behandling av angina pectoris. Utnyttes mulighetene godt nok?